Why WELL Health (TSX:WELL) Stock Surged 22% Yesterday

WELL Health (TSX:WELL) stock surged 22% yesterday after it announced a major acquisition.

| More on:

Telehealth challenger WELL Health Technologies (TSX:WELL) has been on an acquisition spree for the past few years. Every new acquisition expands its platform’s capabilities and potential target market. The latest one, announced yesterday, boosted WELL Health stock by a whopping 22%. 

Here’s a closer look at the latest acquisition and the company’s path forward. 

Growth via acquisitions

Most technology companies grow in one of two ways: intrinsic innovation or extrinsic acquisitions. In other words, they either create innovative new services or acquire smaller firms with unique and innovative products. An ideal tech company focused on growth applies both strategies. 

That’s what WELL Health seems to be doing. Over the past five years, the company has acquired over 11 startups. These include Trinity Healthcare, Cycura Medbase Software, and Indivica. Last year, the acquisition of Circle Medical helped the WELL Health team enter the U.S. market. 

This year, the team seems to be advancing this U.S. entry further. WELL Health acquired CRH Medical, a company focused on products and services for the treatment of gastrointestinal diseases. The deal is worth US$369.2 million (CA$471 million) and could add significantly to WELL Health’s top line and bottom line. 

CRH’s footprint is spread across 13 states in the U.S. and thousands of medical practitioners in this niche. According to WELL Health, the acquisition should enhance revenue per share by roughly 120% and EBITDA per share by almost 800% in 2021. In other words, the deal creates tremendous value for shareholders. 

Funding

The deal is partly financed by a private placement led by billionaire investor and early investor Mr. Li Ka-shing. Along with a consortium of financial institutions, these private investors have deployed $295.5 million into WELL Health’s book.

This is a clear green flag. WELL Health has bagged a deal that is likely to create value for shareholders and entrenches its platform in the largest healthcare market in the world. It’s also being funded by sophisticated investors with deep pockets and an unimpeachable track record. 

WELL Health’s stock valuation

The private placement led by Mr. Li Ka-Shing was sealed at $9.8 per share. Meanwhile, WELL Health stock currently trades at $9. That means smart money investors believe the stock is undervalued. 

The CRH deal could be the clearest indication yet that WELL Health’s top line is about to surge in 2021. This acquisition alone should push the company far above its target $100 million in annual sales. Meanwhile, its market capitalization is $1.46 billion, which implies a price-to-sales ratio of under 14.6. That’s a fair ratio for a company growing this rapidly.

To sum up, WELL Health stock seems undervalued when you account for its access to debt and equity financing and the potential for rapid growth via acquisitions. 

Bottom line

WELL Health stock surged 22% yesterday after it announced a major acquisition. Deals like these add tremendous value for shareholders. The stock hasn’t priced this in yet, which creates an opportunity for retail investors. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL. The Motley Fool owns shares of CRH Medical.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »